Results 161 to 170 of about 150,968 (195)
DVL, a Lectin from <i>Dioclea violacea</i> Seeds, Disturbs the Proteomic Profile of <i>Candida krusei,</i> Leading to Cell Death. [PDF]
Silva RRS +7 more
europepmc +1 more source
Repurposing loratadine to reverse colistin resistance in <i>Klebsiella pneumoniae</i> through targeting lipid A modification. [PDF]
Wu X +11 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Multidrug resistance-associated proteins in glaucoma surgery
Graefe's Archive for Clinical and Experimental Ophthalmology, 2000Multidrug resistance (MDR) describes the phenomenon of cross-resistance between different cytostatic agents which are structurally and functionally dissimilar. Two recently discovered proteins, lung resistance protein (LRP) and the multidrug resistance-related protein (MRP) have been implicated in the development of MDR.
J, Esser +6 more
openaire +2 more sources
Plasmodium falciparum expresses a multidrug resistance-associated protein
Biochemical and Biophysical Research Communications, 2004Plasmodium falciparum proteins that efflux toxic metabolic products such as oxidised glutathione (GSSG) are possible targets for anti-malarial drug development. Proteins capable of transporting GSSG and glutathione conjugates include the multidrug resistance-associated transporters (MRPs). A gene, PFA0590w, encoding a MRP homologue, has been identified
Antonios, Klokouzas +6 more
openaire +2 more sources
Multidrug resistance-associated protein (MRP) in haematological malignancies
Leukemia & Lymphoma, 1996The presence of multidrug resistant cells, either acquired or de novo, severely limits treatment outcome in haematological malignancies. Although expression of the Mr 170,000 P-glycoprotein drug pump is likely to play a role in multidrug resistance (MDR) in haematological malignancies, it is now evident that other MDR mechanisms may be operational as ...
K, Nooter, H, Burger, G, Stoter
openaire +2 more sources
Pharmacogenomics of Human Multidrug Resistance Associated Proteins
Current Pharmacogenomics and Personalized Medicine, 2008Inter-individual variations in response to pharmacotherapy such as adverse effects, treatment resistance and toxicities affect all patient populations. Multidrug resistance associated proteins (MRPs) work as efflux pumps for many xenobiotics and endogenous substances and hence, can affect the drug concentration at the target site which governs ...
Shu-Feng Zhou, Jana Fulcher
openaire +1 more source
Multidrug resistance‐associated proteins and implications in drug development
Clinical and Experimental Pharmacology and Physiology, 2009Summary1. The multidrug resistance‐associated proteins (MRPs) belong to the ATP‐binding cassette superfamily (ABCC family) of transporters that are expressed differentially in the liver, kidney, intestine and blood–brain barrier. There are nine human MRPs that transport a structurally diverse array of endo‐ and xenobiotics as well as their conjugates.2.
Ya-He, Liu +4 more
openaire +2 more sources
The Multidrug Resistance-Associated Protein — MRP
1995The development of the multidrug resistant (MDR) phenotype in cancer cells is the major obstacle to successful chemotherapy. Elucidation of the mechanisms that determine inherent resistance or chemotherapy-induced resistance of human tumors to many of the anticancer agents currently used in the clinic, is of great interest to researchers and great ...
Dominic Fan +4 more
openaire +1 more source

